News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004
5-Amino-1MQ isnt your average fat-loss solution its a metabolic peptide that targets the cellular roots of aging, insulin resistance, and fat accumulation
Scientific References (External Links) Drug Testing and Analysis: Detection and in vitro metabolism of AOD9604 View Study Endocrinology: The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice View Study Hormone Research: Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone View Study Current Opinion in Investigational Drugs: AOD-9604 Metabolic View Study
New peptide drugs are being developed for more effective treatments, with over 100 already approved by the FDA, highlighting their well-researched and regulated nature
Typically given into a muscle
Allow alcohol to dry completely before injecting